Sign Up to like & get
recommendations!
0
Published in 2025 at "Pulmonary Circulation"
DOI: 10.1002/pul2.70215
Abstract: ABSTRACT Pericardial effusion (PEF) in PAH may be a marker of worsening disease or associated with autoimmune conditions. Sotatercept was not initially reported as associated with the development or progression of PEF. We describe PAH…
read more here.
Keywords:
pah;
taking sotatercept;
progressive pericardial;
pericardial effusion ... See more keywords